NLS Pharmaceutics advances Kadimastem merger with fundraising milestone

NLS Pharmaceutics Ltd., a Swiss biopharmaceutical company focused on therapies for rare central nervous system disorders, and Kadimastem Ltd., an Israeli cell therapy innovator, have ... Read More